Characterization of MHC Class I and Class II Immunopeptides in Lung Cancer From Needle-sized Biopsies Using an Optimized High-throughput Workflow - Biognosys

Characterization of MHC Class I and Class II Immunopeptides in Lung Cancer From Needle-sized Biopsies Using an Optimized High-throughput Workflow

Posters

Poster presented at ASBMB 2022

Presenter: Nigel Beaton
Sunday, August 14

Back to Resources overview

Contact

    By submitting this form, you confirm that you consent to Biognosys processing of your personal data for the purposes and in the manner as described in our Privacy Notice.

    Close banner

    New: Spectronaut® 19

    Unlock Your Data's True Story

    New: Spectronaut® 19

    Unlock Your Data's True Story

    Learn More